Skip to content

Truncal Blocks Versus Wound Infiltration for SICD

Comparing Truncal Blocks Versus Wound Infiltration for Subcutaneous Implantable Cardioverter Defibrillator Implantation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04974762
Enrollment
24
Registered
2021-07-23
Start date
2019-01-23
Completion date
2022-02-18
Last updated
2022-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraoperative Pain, Postoperative Pain

Keywords

Subcutaneous implantable cardioverter-defibrillators (S-ICD), Truncal blocks

Brief summary

This is a single-center, randomized and prospective trial of all patients undergoing S-ICD implantation. Subjects will only be eligible for this study if they are ≥ 18 years of age and eligible to undergo S-ICD implant at Mount Sinai Morningside Hospital. They will be randomized to receive either surgical infiltration of local anesthetic or truncal blocks. Intraoperative and postoperative data will be collected including total opioid use, pain scores postprocedure, total postoperative narcotic need and length of stay.

Detailed description

This is a single-center, randomized and prospective trial of all patients undergoing S-ICD implantation. Subjects will only be eligible for this study if they are ≥ 18 years of age and eligible to undergo S-ICD implant at Mount Sinai Morningside Hospital. They will be randomized to receive either surgical infiltration of local anesthetic or truncal blocks. Intraoperative and postoperative data will be collected including total opioid use, pain scores postprocedure, total postoperative narcotic need and length of stay. The procedures involved for the study are the placement of the described truncal blocks or wound infiltration. Data to be collected are patient demographics, history of present illness, past medical history, and pain management techniques required (i.e non-narcotics and narcotics use). In addition, age, race, gender and BMI will also be collected. Intraoperative analgesia requirements, postoperative analgesia requirements, duration of procedure and length of stay will also be collected.

Interventions

PROCEDUREWound infiltration

Surgical wound infiltration by proceduralist

PROCEDURETruncal blocks

Truncal blocks provided by anesthesiology team for device placement

Sponsors

Icahn School of Medicine at Mount Sinai
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

The researcher assessing the subjects postoperatively will be different from the anesthesiologist that performs the interventions.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients over 18 years of age * Patients undergoing S-ICD placement

Exclusion criteria

* Allergy to amide local anesthetics

Design outcomes

Primary

MeasureTime frameDescription
Intraoperative and postoperative opioid consumptionUp to Post-Op Day 10Total intraoperative and postoperative opioid consumption of subjects

Secondary

MeasureTime frameDescription
Sedation (propofol) requirements intraoperativelyDay 1, Day of SurgeryTotal propofol required by subjects intraoperatively
Number of participants with ICU stayUp to Post-Op Day 10Need of intensive care unit (ICU) stay
Duration of ICU stayUp to Post-Op Day 10Duration of intensive care unit (ICU) stay
Non-opioid analgesic consumptionUp to Post-Op Day 10Total intraoperative and postoperative non-opioid analgesic consumption of subjects
Total procedure timeDay 1 at SurgeryTotal duration of procedure time measured in minutes
Length of stayDay 1 at SurgeryLength of time in the postanesthesia care unit measured in minutes
Visual Analog Pain scoreUp to Post-Op Day 10Visual Analog Pain Score (VAS) - total scale from 0-10, with higher score indicating more pain

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026